Laure‐Hélène Préta

Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273)

Laure‐Hélène Préta, Adrien Contejean, Francesco Salvo et al. · British Journal of Clinical Pharmacology · 2022 · 33 citations · Full text

Herpes Zoster Reporting, Immunology, Flu Vaccination +21

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study

Laurent Chouchana, Laure‐Hélène Préta, Mylène Tisseyre et al. · Kidney International · 2021 · 29 citations · Full text

Coronavirus Disease 2019, Chronic Kidney Disease, Antiviral Drug Development +10

Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours

Romain Cohen, Laure‐Hélène Préta, Valentin Joste et al. · British Journal of Clinical Pharmacology · 2018 · 20 citations · Full text

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

Laurent Chouchana, Sana Boujaafar, Inès Gana et al. · Therapeutic Drug Monitoring · 2020 · 12 citations · Full text

Population Pharmacokinetics of Abacavir in Pregnant Women

Floris Fauchet, Jean‐Marc Tréluyer, Laure‐Hélène Préta et al. · Antimicrobial Agents and Chemotherapy · 2014 · 11 citations · Full text

Population Approach, Treatment And Prevention, Nonpregnant Women +12